Lepro Herbals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.30 M
as on 16-11-2024
- Company Age 33 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 89.90 Cr
as on 16-11-2024
- Satisfied Charges ₹ 16.22 Cr
as on 16-11-2024
- Revenue -1.41%
(FY 2023)
- Profit -79.59%
(FY 2023)
- Ebitda -13.54%
(FY 2023)
- Net Worth 1.17%
(FY 2023)
- Total Assets 17.97%
(FY 2023)
About Lepro Herbals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.30 M.
The company currently has active open charges totaling ₹89.90 Cr. The company has closed loans amounting to ₹16.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahesha Kotnala and Soumitra Bhowmick serve as directors at the Company.
- CIN/LLPIN
U74899DL1991PTC045667
- Company No.
045667
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lepro Herbals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesha Kotnala  | Director | 07-Apr-2009 | Current |
| Soumitra Bhowmick | Director | 07-Apr-2009 | Current |
Financial Performance of Lepro Herbals.
Lepro Herbals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.41% decrease. The company also saw a substantial fall in profitability, with a 79.59% decrease in profit. The company's net worth moved up by a moderate rise of 1.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lepro Herbals?
In 2023, Lepro Herbals had a promoter holding of 75.77% and a public holding of 24.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Oct 2021 | ₹3.00 Cr | Open |
State Bank Of India Creation Date: 28 Dec 2007 | ₹66.90 Cr | Open |
Citi Bank N.A. Creation Date: 06 Aug 2001 | ₹10.00 Cr | Open |
How Many Employees Work at Lepro Herbals?
Lepro Herbals has a workforce of 130 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lepro Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lepro Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
